Morningstar Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
SAM
Morningstar Investment Management's BMY Position: Q2 2026 in Review
Morningstar Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 60,529 shares worth $3.67M. The position accounts for 0.23% of the portfolio, ranked #107.
Morningstar Investment Management first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.32M in Q3 2025. 1,390 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Morningstar Investment Management held 60,529 shares of Bristol-Myers Squibb worth $3.67M as of Q2 2026.
- Morningstar Investment Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.23% of Morningstar Investment Management's portfolio in Q2 2026, its #107 holding.
- Morningstar Investment Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
- Morningstar Investment Management's Bristol-Myers Squibb position peaked at $7.32M in Q3 2025.
- 1,390 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Morningstar Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.